CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Quest Patent Research Corp  (QPRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QPRC's Revenue Growth by Quarter and Year

Quest Patent Research's Revenue results by quarter and year




QPRC Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - - 0.07 0.18
III Quarter September - 0.58 0.71 0.15
II Quarter June 6.21 0.64 0.33 0.06
I Quarter March 0.86 0.02 0.16 0.12
FY   7.07 1.24 1.27 0.51



QPRC Revenue second quarter 2018 Y/Y Growth Comment
Quest Patent Research Corp achieved in the second quarter, above Company average Revenue surge of 869.63% year on year, to $ 6.21 millions.

Looking into second quarter results within Biotechnology & Drugs industry 4 other companies have achieved higher Revenue growth. While Quest Patent Research Corp' s Revenue doubling of 869.63% ranks overall at the positon no. 51 in the second quarter.




QPRC Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - -61.11 % -48.57 %
III Quarter September - -18.31 % 373.33 % -54.55 %
II Quarter June 869.63 % 93.94 % 450 % 0 %
I Quarter March 4200 % -87.5 % 33.33 % -42.86 %
FY   - -2.36 % 149.02 % -

Financial Statements
Quest Patent Research's second quarter 2018 Revenue $ 0.00 millions QPRC's Income Statement
Quest Patent Research's second quarter 2017 Revenue $ 0.00 millions Quarterly QPRC's Income Statement
New: More QPRC's historic Revenue Growth >>


QPRC Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - -90.14 % 20 %
III Quarter September - -9.38 % 115.15 % 150 %
II Quarter June 621.59 % 3100 % 106.25 % -50 %
I Quarter March - -71.43 % -11.11 % -65.71 %
FY (Year on Year)   - -2.36 % 149.02 % -




Revenue second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #5
Healthcare Sector #19
Overall #51

Revenue Y/Y Growth Statistics
High Average Low
5323.32 % 855.18 % -96.51 %
(Mar 31 2018)  
Revenue second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #5
Healthcare Sector #19
Overall #51
Revenue Y/Y Growth Statistics
High Average Low
5323.32 % 855.18 % -96.51 %
(Mar 31 2018)  

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Quest Patent Research's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
33052.28 % 1902.94 % -99.55 %
(Mar 31 2018)  


QPRC's II. Quarter Q/Q Revenue Comment
Quest Patent Research Corp achieved in the II. Quarter 2018 below company average Revenue doubling of 621.59% quarter on quarter, to $ 6.21 millions.

Within Biotechnology & Drugs industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is 42.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #15
Overall #42
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #15
Overall #42
Revenue Q/Q Growth Statistics
High Average Low
33052.28 % 1902.94 % -99.55 %
(Mar 31 2018)  


QPRC's II. Quarter Q/Q Revenue Comment
Quest Patent Research Corp achieved in the II. Quarter 2018 below company average Revenue doubling of 621.59% quarter on quarter, to $ 6.21 millions.

Within Biotechnology & Drugs industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is 42.


Quest Patent Research's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative Revenue 12 Months Ending $ 7.64 $ 2.07 $ 1.23 $ 1.30 $ 1.43
Y / Y Revenue Growth (TTM) 434.07 % 84.96 % -2.58 % -5.05 % 76.29 %
Year on Year Revenue Growth Overall Ranking # 52 # 253 # 2994 # 2523 # 51
Seqeuential Revenue Change (TTM) 268.68 % 68.32 % -5.49 % -8.94 % 27.68 %
Seq. Revenue Growth (TTM) Overall Ranking # 21 # 68 # 3597 # 3730 # 20




Cumulative Revenue growth Comment
Quest Patent Research saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 434.07% year on year, to $ 8 millions if the fiscal year would have ended in Jun 30 2018.
Quest Patent Research's trailing twelve months Revenue growth was higher than company's average 128.84% and higher than 84.96% growth in Mar 31 2018. Company had also second best Revenue growth in Biotechnology & Drugs industry.
But sequential increase was less at 268.68 % from $2.07 millions recorded in twelve months ending a quarter Mar 31 2018.
Still this was confirmation of positive momentum, as the average sequential gain lays at 43.2%.
The progress was much stronger sequentially exhibited at 268.68 % jump from $2.07 millions in the period from Mar 31 2018 to Jun 30 2017.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 52, from total ranking in previous quarter at 253.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
43.2 %
-68.59 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 2
Healthcare Sector # 15
Overall # 52

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
128.84 %
-77.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 7
S&P 500 # 21
Cumulative Revenue growth Comment
Quest Patent Research saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 434.07% year on year, to $ 8 millions if the fiscal year would have ended in Jun 30 2018.
Quest Patent Research's trailing twelve months Revenue growth was higher than company's average 128.84% and higher than 84.96% growth in Mar 31 2018. Company had also second best Revenue growth in Biotechnology & Drugs industry.
But sequential increase was beneth at 268.68 % from $2.07 millions achieved in twelve months ending a quarter before Lewis  Wood went on.
In spite of, this was evidence of strength, while the usual sequential Revenue advancement lays at 43.2%.
The progress is even higher sequentially clinched at 268.68 % rise from $2.07 millions in twelve months ending a quarter Mar 31 2018.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 52, from total ranking in previous quarter at 253.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
43.2 %
-68.59 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 2
Healthcare Sector # 15
Overall # 52

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
128.84 %
-77.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 7
S&P 500 # 21


You need to upgrade your Flash Player




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QPRC's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for QPRC's Competitors
Revenue Growth for Quest Patent Research's Suppliers
Revenue Growth for QPRC's Customers

You may also want to know
QPRC's Annual Growth Rates QPRC's Profitability Ratios QPRC's Asset Turnover Ratio QPRC's Dividend Growth
QPRC's Roe QPRC's Valuation Ratios QPRC's Financial Strength Ratios QPRC's Dividend Payout Ratio
QPRC's Roa QPRC's Inventory Turnover Ratio QPRC's Growth Rates QPRC's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2018
Neurocrine Biosciences Inc  1,429.68 %$ 1,429.676 millions
Dynavax Technologies Corp  1,094.29 %$ 1,094.286 millions
United Cannabis Corp  1,034.34 %$ 1,034.337 millions
Macrogenics Inc  1,030.49 %$ 1,030.492 millions
Genesis Healthcare, Inc.  917.00 %$ 917.001 millions
Quest Patent Research Corp  876.64 %$ 876.639 millions
Revance Therapeutics, Inc.  814.67 %$ 814.667 millions
Enanta Pharmaceuticals Inc  662.38 %$ 662.375 millions
Tetraphase Pharmaceuticals Inc  630.08 %$ 630.076 millions
Bioscrip, Inc.  606.00 %$ 605.996 millions
Blueprint Medicines Corp  603.55 %$ 603.548 millions
Reshape Lifesciences Inc.  602.09 %$ 602.094 millions
Pieris Pharmaceuticals, Inc.  530.97 %$ 530.971 millions
Bionik Laboratories Corp.  472.82 %$ 472.821 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

POPE's Profile

Stock Price

POPE's Financials

Business Description

Fundamentals

Charts & Quotes

POPE's News

Suppliers

POPE's Competitors

Customers & Markets

Economic Indicators

POPE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071